Accelerating Immune Disorder Research with 5M Harmonized Cells
Key Highlights
A South San Francisco-based translational research company is developing targets in the field of inflammatory diseases by targeting the underlying dysregulation that drives diseases. They needed high-quality multi-modal public datasets to achieve their goal.
The company faced challenges in finding high-quality public datasets that are well-annotated with metadata. Additionally, they encountered hurdles in annotating cell types in single-cell datasets and experienced issues with the seamless integration of public data into their infrastructure, all due to its low quality.
Elucidata's team delivered high-quality, ML-ready public datasets of multiple modalities, completely annotated with metadata, facilitating seamless integration into company’s internal infrastructure through APIs.
Elucidata helped them save approximately 1600 hours by delivering 5 million cells and 11,000 relevant multi-modal samples and annotating cell types for single cells with reference markers, to help expedite their research goals.
Thank you for showing interest! You will receive the Case Study in your Mailbox shortly.
.svg)
.svg)
%201%20(1).svg)
.svg)
%201.svg){kind=icon}
.svg)
%20(1).svg)
